Knowledge attitude and practice of pharmacovigilance among community pharmacy in India: a questionnaire study

Sindhu Selvam; S. Karthik; Asha Rani Sankaravadivel; Kalai Selvi Durai; Narmatha Rajarathinam; Sneha Raja; Ishwaryaa Jothibabu

doi:10.18203/2319-2003.ijbcp20242421

Authors

Sindhu Selvam Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
S. Karthik Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
Asha Rani Sankaravadivel Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
Kalai Selvi Durai Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
Narmatha Rajarathinam Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
Sneha Raja Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India
Ishwaryaa Jothibabu Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, SRIHER, Porur, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20242421

Keywords:

Adverse effect, Pharmacovigilance, PvPI

Abstract

Background: Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The Pharmacovigilance Program of India (PvPI), which has been functioning since July 2010, was renamed by the Ministry of Health and Family Welfare of the Indian government. This study main objective to assess the current knowledge, attitude and practice of pharmacovigilance in community pharmacist.

Methods: Self-prepared and validated questionnaires were distributed among community pharmacists in India through online forms for 8 months, a cross-sectional questionnaire-based survey was used, with convenience sampling utilized. Responses from 2205 subjects were analyzed.

Results: The primary objective of this study was to assess the demographic details of the community pharmacists as well as the distribution of knowledge, Attitude, Practice on Pharmacovigilance, out of 2205 Community Pharmacist 1109 (50.3%) were male and 1016 (49.7%) were female. More than half of the respondents (54%) was familiar about the definition of pharmacovigilance. Out of 2205 respondents, 240 respondents thought that reporting adverse drug reaction is unnecessary. Among 2205 respondents, 445 respondents have not experienced ADR in their patients during their professional practice.

Conclusions This study determined the Assessment of Knowledge, Attitude and practice of Pharmacovigilance among Community Pharmacist in India. According to this study, community pharmacists are good in attitude but they were not knowledgeable and not effective in practice.

Metrics

Metrics Loading ...

References

Kassa Alemu, Tessema Tsehay Biru, "Health care professionals’ knowledge, attitude, and practice towards adverse drug reaction reporting and associated factors at selected public hospitals in northeast ethiopia: a cross-sectional study". IR BioMed. 2019:1-11.

Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa. Br J Clin Pharmacol. 2021;89(2):491-509.

"DIRECTIVE 2010/84/EU, Article 101"). 2015. Available at: ec.europa.eu. Accessed on 20th December 2023.

Sah RK, Chandane RD, Krishna, Manocha S, Kapur A. Knowledge, attitude and practice of pharmacovigilance among community pharmacists in Delhi, India. Int J Basic Clin Pharmacol 2017;6:618-23.

Gupta YK. Ensuring patient safety - launching the new pharmacovigilance programme of India. Pharma times. 2010;42(8):21-6.

Kalaiselvan V, Prasad T, Singh A. Current status of adverse drug reactions monitoring centres under pharmacovigilance programme of india. Indian J Pharm Prac. 2014;7:19-22.

Lihite RJ, Lahkar M. An update on the Pharmacovigilance Programme of India. Front. Pharmacol. 2015;6:194.

Salim M. The current perspective of community pharmacists towards pharmacovigilance. J Pharmacovigil. 2015;3:180.

Hussain R, Hassali MA, Hashmi F, Akram T. Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. J Pharm Policy Pract. 2021;14(1):1-3.

Jude A Udoye, Raymond I Ozolua, Jude Nwokike Assessment of the knowledge, attitude and practice of pharmacovigilance by pharmacists in two states in south eastern Nigeria. J Pharm Res. 2018;17(5):937-45.

Srinivasan V, Sheela D, Mridula D. Knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital–A questionnaire study. Biomed Pharmacol. J. 2017;10(3):1441-7.

Korde RA, Radhika MS. A KAP study of pharmacovigilance among junior residents and interns of a tertiary care hospital. Int J Basic Clin Pharmacol. 2018;7(11):2178-83.

Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6:45-52.

Upadhyaya HB, Vora MB, Nagar JG, Patel PB, Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. J Adv Pharm Technol Res. 2015;6:29-34.

Wadagbalkar P, Tiwari V, Raipurkar S. Knowledge, attitude and practice of interns regarding pharmacovigilance in a tertiary hospital of Madhya Pradesh. J Adv Med Dent Scie Res. 2016;4(6):216-9.